We further showed that age-related hypertension is reversed by the treatment of aged mice with recombinant human Trx1, demonstrating a potential therapeutic efficacy of Trx in hypertension and potentially in many other cardiovascular diseases (Das et al., 2018; Hilgers et al., 2017). This evidence concerns the gene TXN and cardiovascular disorder.